Morningstar Inc (MORN) is not a strong buy for a beginner investor with a long-term strategy at this moment. While the company has shown some financial growth in revenue and EPS, the deceleration in key growth platforms like PitchBook, coupled with competitive and strategic challenges, raises concerns. Technical indicators suggest the stock is overbought, and there are no strong proprietary trading signals or significant positive catalysts to justify immediate action.
The MACD is positive and expanding, suggesting bullish momentum. However, the RSI is at 82.294, indicating the stock is overbought. The price is near a resistance level (R1: 188.828), with limited upside potential in the short term. Moving averages are converging, which could signal a potential reversal or consolidation.

Hedge funds are significantly increasing their positions in MORN, with a 395.58% increase in buying activity over the last quarter. Revenue and EPS have shown YoY growth, and gross margin has improved.
Analysts have lowered price targets due to deceleration in growth for key platforms like PitchBook and challenges with competition, sales cycles, and AI strategy. The RSI indicates the stock is overbought, and technical resistance levels limit short-term upside potential. No recent congress trading data or significant insider activity.
In Q4 2025, revenue increased by 8.48% YoY to $641.1 million, and EPS grew by 3.69% YoY to 2.81. However, net income dropped by 1.54% YoY to $115.1 million, indicating some profitability challenges. Gross margin improved by 2.40% YoY to 53.78%.
Analysts have lowered price targets recently: BMO Capital reduced the target to $193 from $257, citing growth deceleration and strategic challenges, while UBS lowered the target to $280 from $320 but maintained a Buy rating.